10th,March,2008  -   The Food and Drug Administration said a proposed postsurgery muscle drug made by Schering-Plough Corp. appears to be safe for use in adult patients, although there is some chance of allergic reaction.

According to the FDA panel,the drug, sugammadex, would be used to reverse the effects of muscle-paralyzing drugs used in some surgeries. It is estimated that about half of patients undergoing surgery receive some type of product to induce complete muscle paralysis, along with other drugs used to make a person unconscious.

The FDA said an updated safety review of the drug would be presented at tomorrow's panel meeting, which could shed more light on allergic reactions to it.